Coloplast A/S Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in Ostomy Care. Q2 EBIT margin1 held steady at 27%. Reported …
Participants Rachel Ulsh; Vice President, Investor Relations; Freshpet Inc William Cyr; Chief Executive Officer, Director; Freshpet Inc Todd Cunfer; Chief Financial Officer; Freshpet Inc Scott Morris; President, Co-Founder; Freshpet Inc Ken Goldman; Analyst; JPMorgan Peter Benedict; Analyst; Robert W. Baird & Co., Inc. Bill …
Participants David DeMartino; Senior Vice President - Investor Relations; Zimmer Biomet Holdings Inc Ivan Tornos; President, Chief Executive Officer & Director; Zimmer Biomet Holdings Inc Suketu Upadhyay; Chief Financial Officer, Executive Vice President; Zimmer Biomet Holdings Inc Robert Marcus; Analyst; JPMorgan Chase & Co …
Group revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just - Evotec Biologics with continuing growth momentum Strong progress in strategic protein degradation partnership with Bristol Myers Squibb Strategy building on technology and science leadership: Focus …
Participants Angela Bitting; Senior Vice President, Corporate Affairs; Chief Corporate Responsibility Officer; Twist Bioscience Corp Emily Leproust; Chairman of the Board, Chief Executive Officer; Twist Bioscience Corp Patrick Finn; President, Chief Operating Officer; Twist Bioscience Corp Adam Laponis; Chief Financial Officer; Twist Bioscience Corp …
Credit Suisse Services AG struck a deal with U.S. regulators that will see it pay a total of $511 million, including forfeitures, after it pleaded guilty to conspiring to hide billions in offshore accounts held by wealthy U.S. tax evaders. This is the second …
Participants Michael Horowicz; Associate Director, Investor Relations and Strategy; Biontech SE Ugur Sahin; Chief Executive Officer, Member of the Management Board; Biontech SE Oezlem Tuereci; Chief Medical Office, Member of the Management Board; Biontech SE Jens Holstein; Chief Financial Officer; Biontech SE Ryan Richardson; …
As you might know, NatWest Group plc (LON:NWG) just kicked off its latest quarterly results with some very strong numbers. It was overall a positive result, with revenues beating expectations by 3.8% to hit UK£4.0b. NatWest Group reported statutory earnings per share (EPS) UK£0.15, …
LONDON & DENVER & JOHANNESBURG, May 06, 2025--(BUSINESS WIRE)--AngloGold Ashanti plc ("AngloGold Ashanti" or the "Company") and Gold Fields have agreed to pause discussions about a proposed joint venture to combine their Iduapriem and Tarkwa gold mines in Ghana. The companies proposed the combination …
LONDON (Reuters) -European online fashion retailer Zalando reported first-quarter revenue that was stronger than expected, boosted by additional customers and a good start to spring and summer sales, while confirming its 2025 guidance. The multi-brand platform that sells clothes, shoes, and accessories said revenue …